145 related articles for article (PubMed ID: 24315629)
1. Utility of abdominal imaging to assess for liver metastasis in patients with head and neck cancer and abnormal liver function tests.
Chen PG; Schoeff SS; Watts CA; Reibel JF; Levine PA; Shonka DC; Jameson MJ
Am J Otolaryngol; 2014; 35(2):137-40. PubMed ID: 24315629
[TBL] [Abstract][Full Text] [Related]
2. Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma.
Deal AM; Patel MR; Thorp BD; Cannon TY; Shores CG; Zanation AM
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):88-91. PubMed ID: 21987648
[TBL] [Abstract][Full Text] [Related]
3. Liver function studies in the assessment of head and neck cancer patients.
Korver KD; Graham SM; Hoffman HT; McCulloch T; Funk GF
Head Neck; 1995; 17(6):531-4. PubMed ID: 8847212
[TBL] [Abstract][Full Text] [Related]
4. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
5. Liver function tests in metastatic uveal melanoma.
Kaiserman I; Amer R; Pe'er J
Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
[TBL] [Abstract][Full Text] [Related]
6. Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma.
Mouriaux F; Diorio C; Bergeron D; Berchi C; Rousseau A
Ophthalmology; 2012 Aug; 119(8):1590-5. PubMed ID: 22683062
[TBL] [Abstract][Full Text] [Related]
7. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
8. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
9. [Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer].
Sadick M; Schoenberg SO; Hoermann K; Sadick H
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S27-47. PubMed ID: 22456918
[TBL] [Abstract][Full Text] [Related]
10. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
11. [Detection of liver metastases in gynecologic neoplasms by sonography, scintigraphy, computerized tomography and liver enzymes].
Schillinger H; Traeder R; Klosa W; Pohl J
Onkologie; 1988 Oct; 11(5):216-20. PubMed ID: 3059249
[TBL] [Abstract][Full Text] [Related]
12. Advances in imaging in the work-up of head and neck cancer patients.
de Bree R; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2009 Nov; 45(11):930-5. PubMed ID: 19692289
[TBL] [Abstract][Full Text] [Related]
13. The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
Demirci U; Coskun U; Akdemir UO; Benekli M; Kapucu O; Ozkan S; Cakir T; Baykara M; Buyukberber S
Asian Pac J Cancer Prev; 2011; 12(7):1817-20. PubMed ID: 22126572
[TBL] [Abstract][Full Text] [Related]
14. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
[TBL] [Abstract][Full Text] [Related]
16. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of radiologic screening for distant metastases and second primaries in newly diagnosed patients with head and neck cancer.
Jäckel MC; Reischl A; Huppert P
Laryngoscope; 2007 Feb; 117(2):242-7. PubMed ID: 17277617
[TBL] [Abstract][Full Text] [Related]
18. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
Fayad H; Le Pogam A; Lamare F; Fernandez P; Pradier O; Valette G; Visvikis D; Cheze Le Rest C
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):319-28. PubMed ID: 25265252
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound of the abdomen and total bone scintigraphy in patients with cancer of the head and neck.
Lybak S; Olofsson J
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):887-9. PubMed ID: 16273413
[TBL] [Abstract][Full Text] [Related]
20. Liver function tests in patients with computed tomography demonstrated hepatic metastases.
Ottmar MD; Gonda RL; Leithauser KJ; Gutierrez OH
Gastrointest Radiol; 1989; 14(1):55-8. PubMed ID: 2910745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
